Drug intelligence / Profile preview

NIKOVIT Multivitamin Drops

Development stage: Unknown
Lead developer: Uniark Healthcare
Modality: Small Molecules
Administration: Oral

Overview

NIKOVIT Multivitamin Drops is a nutritional supplement developed and marketed by Uniark Healthcare. Formulated as oral drops, it is designed to provide a combination of essential vitamins to support growth, development, and immune function, particularly in infants and young children. The product is part of Uniark's pharmaceutical portfolio offered through its PCD Pharma Franchise model in India. It typically contains a blend of vitamins such as Vitamin A, Vitamin D3, Vitamin C, and B-complex vitamins, which serve as vital cofactors in metabolic processes and help prevent or treat vitamin deficiencies.

Brand names: NIKOVIT Multivitamin Drops
Other names: NIKOVIT Drops

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on NIKOVIT Multivitamin Drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIKOVIT Multivitamin Drops.

Explore the full profile